GGrantIndex
← Leaderboards

David M Allman

University Of Pennsylvania

$20,049,239
Attributed
$26,992,232
Total exposure
18
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.2M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$26,992,232 · 18

By mechanism

R01$22,854,053 · 9
R21$2,682,215 · 6
T32$1,218,214 · 1
R03$237,750 · 2

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “B-Lymphocytes

Research focus

B-LymphocytesAntibodiesResponsePlasma CellsCellsBone MarrowGenesGenerationsTranscription FactorMediatingAutoimmunityPlaySignal TransductionAntigensIn VivoPathway InteractionsResearch StudyKineticsLifeCell PhysiologyAffectMaintenanceInsightEvent

Grant awards (66)

Proteasome Targeting for Alloreactive Plasma Cells$3,810,794
R01 · FY2025 · AI · contact PI
Purinergic Receptors in Myeloma$621,156
R01 · FY2025 · CA · contact PI
Biochemical Mechanisms for Sustained Humoral Immunity$601,509
R01 · FY2025 · AI · contact PI
Immune System Development and Regulation$216,204
T32 · FY2025 · AI · contact PI
Proteasome targeting for alloreactive plasma cells$656,105
R01 · FY2024 · AI · contact PI
Biochemical Mechanisms for Sustained Humoral Immunity$623,408
R01 · FY2024 · AI · contact PI
Immune System Development and Regulation$212,886
T32 · FY2024 · AI · contact PI
The Notch Pathway in Antigen Design$207,772
R21 · FY2024 · AI · contact PI
Proteasome targeting for alloreactive plasma cells$656,561
R01 · FY2023 · AI · contact PI
Biochemical Mechanisms for Sustained Humoral Immunity$648,068
R01 · FY2023 · AI · contact PI
The Notch Pathway in Antigen Design$263,970
R21 · FY2023 · AI · contact PI
Immune System Development and Regulation$213,369
T32 · FY2023 · AI · contact PI
Proteasome targeting for alloreactive plasma cells$688,803
R01 · FY2022 · AI · contact PI
Very early plasma cell differentiation$562,174
R01 · FY2022 · AI · contact PI
Immune System Development and Regulation$205,157
T32 · FY2022 · AI · contact PI
Plasma Cell Regulation by Purinergic Receptors$203,125
R21 · FY2022 · AI · contact PI
Proteasome targeting for alloreactive plasma cells$691,721
R01 · FY2021 · AI · contact PI
Very early plasma cell differentiation$640,370
R01 · FY2021 · AI · contact PI
Plasma Cell Regulation by Purinergic Receptors$243,750
R21 · FY2021 · AI · contact PI
Immune System Development and Regulation$198,076
T32 · FY2021 · AI · contact PI
Proteasome targeting for alloreactive plasma cells$701,208
R01 · FY2020 · AI · contact PI
Very early plasma cell differentiation$562,174
R01 · FY2020 · AI · contact PI
Very early plasma cell differentiation$76,919
R01 · FY2020 · AI · contact PI
Very early plasma cell differentiation$562,174
R01 · FY2019 · AI · contact PI
Very early plasma cell differentiation$577,424
R01 · FY2018 · AI · contact PI
Plasma Cell Priming$201,250
R21 · FY2018 · AI · contact PI
Immune System Development and Regulation$172,522
T32 · FY2018 · AI · contact PI
Origins of serum IgA antibodies$400,000
R01 · FY2017 · AI · contact PI
Plasma Cell Priming$241,500
R21 · FY2017 · AI · contact PI
Origins of serum IgA antibodies$400,000
R01 · FY2016 · AI · contact PI
Long-lived CD19-positive plasma cells$390,720
R01 · FY2016 · AI · contact PI
Control of plasma cell longevity by the IRE1 pathway$201,774
R21 · FY2016 · AI · contact PI
Epigenetic Control of Plasma Cell Differentiation$200,000
R21 · FY2016 · AI · contact PI
Origins of serum IgA antibodies$400,000
R01 · FY2015 · AI · contact PI
Long-lived CD19-positive plasma cells$390,384
R01 · FY2015 · AI · contact PI
Control of plasma cell longevity by the IRE1 pathway$256,722
R21 · FY2015 · AI · contact PI
Epigenetic Control of Plasma Cell Differentiation$240,000
R21 · FY2015 · AI · contact PI
Origins of serum IgA antibodies$400,000
R01 · FY2014 · AI · contact PI
Long-lived CD19-positive plasma cells$390,056
R01 · FY2014 · AI · contact PI
Long-lived CD19-positive plasma cells$366,351
R01 · FY2013 · AI · contact PI
Mechanisms of Lymphoid Lineage Commitment$354,286
R01 · FY2013 · AI · contact PI
Long-lived CD19-positive plasma cells$389,293
R01 · FY2012 · AI · contact PI
Mechanisms of Lymphoid Lineage Commitment$376,900
R01 · FY2012 · AI · contact PI
Mechanisms of Lymphoid Lineage Commitment$376,900
R01 · FY2011 · AI · contact PI
Long-lived antibody secreting cells$190,954
R21 · FY2011 · AI · contact PI
Mechanisms of Lymphoid Lineage Commitment$380,707
R01 · FY2010 · AI · contact PI
Aging of Early B Cell Precursors$304,169
R01 · FY2010 · AG · contact PI
Long-lived antibody secreting cells$231,398
R21 · FY2010 · AI · contact PI
Mechanisms of Lymphoid Lineage Commitment$384,552
R01 · FY2009 · AI · contact PI
Aging of Early B Cell Precursors$307,242
R01 · FY2009 · AG · contact PI
Development of plasmacytoid dendritic cells$294,862
R01 · FY2008 · AI · contact PI
Aging of Early B Cell Precursors$276,518
R01 · FY2008 · AG · contact PI
Development of plasmacytoid dendritic cells$300,573
R01 · FY2007 · AI · contact PI
Aging of Early B Cell Precursors$282,011
R01 · FY2007 · AG · contact PI
MECHANISMS OF LYMPHOID LINEAGE COMMITMENT$348,245
R01 · FY2006 · AI · contact PI
Development of plasmacytoid dendritic cells$309,551
R01 · FY2006 · AI · contact PI
Aging of Early B Cell Precursors$289,665
R01 · FY2006 · AG · contact PI
MECHANISMS OF LYMPHOID LINEAGE COMMITMENT$356,625
R01 · FY2005 · AI
Development of plasmacytoid dendritic cells$317,000
R01 · FY2005 · AI
MECHANISMS OF LYMPHOID LINEAGE COMMITMENT$356,625
R01 · FY2004 · AI
Development of plasmacytoid dendritic cells$317,000
R01 · FY2004 · AI
MECHANISMS OF LYMPHOID LINEAGE COMMITMENT$356,625
R01 · FY2003 · AI
ONTOGENY OF PLASMACYTOID DENDRITIC CELLS$79,250
R03 · FY2003 · AI
MECHANISMS OF LYMPHOID LINEAGE COMMITMENT$356,625
R01 · FY2002 · AI
ONTOGENY OF PLASMACYTOID DENDRITIC CELLS$79,250
R03 · FY2002 · AI
Effect of aging on lymphoid stem cells$79,250
R03 · FY2002 · AG